Elotuzumab-induced interstitial lung disease: the first case report

Tanaka, T; Saito, Y; Kokuho, N; Tamura, H; Terasaki, Y; Seike, M; Gemma, A

Saito, Y (reprint author), Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018; 48 (5): 491

Abstract

Elotuzumab, a humanized immunoglobulin G1 monoclonal antibody targeted against signaling lymphocytic activation molecule F7 (SLAMF7), has recently bee......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索